Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
5
Number of overlapping holdings
12.2%
% of GDOC's 43 holdings also in MEDX
16.7%
% of MEDX's 30 holdings also in GDOC
Overlap by Weight
Sector Drift (GDOC minus MEDX)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in GDOC |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 10.4% | 17.0% | 10.4% |
|
ABBVIE INC | 4.7% | 7.9% | 4.7% |
|
AMGEN INC | 4.6% | 5.9% | 4.6% |
|
BIOGEN IDEC INC | 2.8% | 3.4% | 2.8% |
|
ALNYLAM PHARMACEUTICALS INC | 1.0% | 4.0% | 1.0% |
Position Highlights (Non-Overlapping Exposures)
GDOC Overweight Relative to MEDX
 |
ASTRAZENECA PLC | 6.2% |
|
BOSTON SCIENTIFIC CORP | 5.9% |
 |
NOVO NORDISK A/S-B | 5.8% |
|
INTUITIVE SURGICAL INC | 5.0% |
|
DANAHER CORP | 3.8% |
 |
METTLER-TOLEDO INTERNATIONAL | 3.4% |
|
NEUROCRINE BIOSCIENCES INC | 3.4% |
|
INSULET CORP | 3.4% |
|
HUMANA INC | 3.4% |
|
COOPER COS INC/THE | 3.3% |
GDOC Underweight Relative to MEDX
|
ELI LILLY & CO | -6.6% |
|
NOVARTIS AG-ADR | -6.1% |
|
ASTRAZENECA PLC-SPONS ADR | -5.8% |
|
BRISTOL-MYERS SQUIBB CO | -4.7% |
|
REGENERON PHARMACEUTICALS | -4.5% |
|
JOHNSON & JOHNSON | -4.5% |
|
MERCK & CO. INC. | -4.2% |
|
PFIZER INC | -4.0% |
 |
ALKERMES PLC | -3.4% |
|
ABBVIE INC | -3.3% |